help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 14, 2009
Molecular Endocrinology, doi:10.1210/me.2009-0008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
23/8/1264    most recent
Author Manuscript (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Parnaud, G.
Right arrow Articles by Halban, P. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parnaud, G.
Right arrow Articles by Halban, P. A.

Submitted on January 7, 2009
Accepted on May 4, 2009

Signaling pathways implicated in the stimulation of beta-cell proliferation by extracellular matrix

Géraldine Parnaud*, Eva Hammar, Pascale Ribaux, Marc Y. Donath, Thierry Berney, and Philippe A. Halban

University of Geneva, Department of Genetic Medicine and Development, University Medical Center, Geneva, Switzerland; Cell Isolation and Transplantation Center, Division of Surgical Research, Department of Surgery, University Hospital, Geneva, Switzerland; and Division of Endocrinology and Diabetes, University Hospital, Zurich, Switzerland

* To whom correspondence should be addressed. E-mail: geraldine.parnaud{at}.unige.ch.

Laminin-5-rich extracellular matrix derived from 804G cells (804G-ECM) induces spreading, improves glucose-stimulated insulin secretion, and increases survival and proliferation of rat pancreatic beta-cells. The aim of the study was to determine growth signaling pathways activated by ECM with a particular focus on Ca2+-dependent transcription factors. 804G-ECM increased rat beta-cell proliferation and this stimulation was glucose- and Ca2+-dependent. NF-{kappa}B nuclear translocation as well as IkB{alpha} gene expression were also Ca2+-dependent. Inhibition of NF-{kappa}B almost completely blocked 804G-ECM-stimulated beta-cell proliferation as did the soluble IL-1 receptor antagonist IL-1Ra. 804G-ECM-induced proliferation was also blocked by cyclosporin A and the VIVIT peptide suggesting involvement of NFAT/calcineurin. Use of selective inhibitors further implicated other pathways in this process. Inhibition of PI3 kinase and protein kinase A both prevented beta-cell replication stimulated by 804G-ECM. Conversely, inhibition of MAPK, JNK, p38 and GSK3{beta} increased beta-cell proliferation on 804G-ECM. Our results suggest that Ca2+ entry which is necessary for increased beta-cell proliferation on 804G-ECM is also involved in 804G-ECM induced NF-{kappa}B activity. It is proposed that increased cytosolic Ca2+ leads to activation of the transcription factors NFAT and NF-{kappa}B that in turn increase beta-cell proliferation. Activation of PI3 kinase by 804G-ECM also increases proliferation possibly by synergistic co-activation of NFAT via inhibition of GSK3{beta}, while IL-1{beta} may amplify the process by feed-forward activation of NF-{kappa}B. Conversely, inhibition of the MAPK pathway increased beta-cell proliferation indicating a counter-regulatory restraining role for this signaling pathway.


Key words: Beta-cell • proliferation • extracellular matrix • signaling pathways







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society